Precautionary recall of medication used for pain and inflammation due to incomplete patient information

Specific batches of Napralief 250mg Gastro‑Resistant Tablets are being recalled because important safety and dosage information is missing from both the patient information leaflet and the outer carton.

Follow this news feed: